122 related articles for article (PubMed ID: 8396059)
1. Pharmacological action of (-)-(2S,3aR,7aS)-1-[(S)-N-[(S)-1-carbonyl-3- phenylpropyl]alanyl]hexahydro-2-indolinecarboxylic acid (trandolaprilat) in isolated smooth muscle preparations.
Sekiguchi N; Ishii Y; Fujikura H; Hasegawa Y; Takayanagi I
Gen Pharmacol; 1993 May; 24(3):585-90. PubMed ID: 8396059
[TBL] [Abstract][Full Text] [Related]
2. The endothelium and vascular effects of the ACE inhibitor trandolaprilat.
Vidal M; Joly G; Mombouli JV; Boulanger CM; Vanhoutte PM
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S1-5. PubMed ID: 7527094
[TBL] [Abstract][Full Text] [Related]
3. Potentiation by trandolaprilat of the endothelium-dependent hyperpolarization induced by bradykinin.
Illiano S; Mombouli JV; Nagao T; Vanhoutte PM
J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S6-10. PubMed ID: 7527103
[TBL] [Abstract][Full Text] [Related]
4. Effects of the new angiotensin-I-converting enzyme inhibitor imidapril on the responses of isolated vascular preparations to various agonists.
Kubo M; Fujitsuka T; Ishida R
Arzneimittelforschung; 1992 Apr; 42(4):446-51. PubMed ID: 1642667
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of bradykinin effects and inhibition of kininase activity in isolated smooth muscle.
Schaffel R; Rodrigues MS; Assreuy J
Can J Physiol Pharmacol; 1991 Jul; 69(7):904-8. PubMed ID: 1659490
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-dependent effect of perindopril and enalaprilat in rat thoracic aorta.
Fang ZY; Li YF; Zhang LL; Liu DJ; Li YQ
Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):519-23. PubMed ID: 9863146
[TBL] [Abstract][Full Text] [Related]
7. Different effects of angiotensin-converting enzyme inhibition in human arteries and veins.
Yang Z; Arnet U; von Segesser L; Siebenmann R; Turina M; Lüscher TF
J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S17-22. PubMed ID: 7508047
[TBL] [Abstract][Full Text] [Related]
8. Previous exposure to bradykinin unmasks an endothelium-dependent relaxation to the converting enzyme inhibitor trandolaprilat in isolated canine coronary arteries.
Desta B; Nakashima M; Kirchengast M; Vanhoutte PM; Boulanger CM
J Pharmacol Exp Ther; 1995 Feb; 272(2):885-91. PubMed ID: 7531766
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-dependent relaxation by angiotensin-converting enzyme inhibitors in canine femoral arteries.
Moroi M; Akatsuka N; Fukazawa M; Hara K; Ishikawa M; Aikawa J; Namiki A; Yamaguchi T
Am J Physiol; 1994 Feb; 266(2 Pt 2):H583-9. PubMed ID: 8141360
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide pathway-mediated relaxant effect of bradykinin in the guinea-pig isolated trachea.
Schlemper V; Calixto JB
Br J Pharmacol; 1994 Jan; 111(1):83-8. PubMed ID: 8012728
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Kajiwara Y; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the effects of two new arginine/citrulline analogues on constitutive and inducible nitric oxide synthases in rat aorta.
Joly GA; Narayanan K; Griffith OW; Kilbourn RG
Br J Pharmacol; 1995 Jun; 115(3):491-7. PubMed ID: 7582462
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of angiotensin converting enzyme by CV-3317, a non-sulfhydryl compound.
Inada Y; Terashita Z; Imura Y; Tanabe M; Nishikawa K; Kikuchi S
Jpn J Pharmacol; 1986 Sep; 42(1):99-108. PubMed ID: 3025487
[TBL] [Abstract][Full Text] [Related]
14. Demonstration of extrapulmonary activity of angiotensin converting enzyme in intact tissue preparations.
Lembeck F; Griesbacher T; Eckhardt M
Br J Pharmacol; 1990 May; 100(1):49-54. PubMed ID: 2164861
[TBL] [Abstract][Full Text] [Related]
15. Endothelial factors involved in the bradykinin-induced relaxation of the guinea-pig aorta.
Kamei M; Yoneda Y; Suzuki H
J Smooth Muscle Res; 2000 Aug; 36(4):127-35. PubMed ID: 11286296
[TBL] [Abstract][Full Text] [Related]
16. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
Persson K; Andersson RG
J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
[TBL] [Abstract][Full Text] [Related]
17. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of converting-enzyme inhibitors for angiotensin I versus bradykinin hydrolysis reactions.
Brooks RR; Miller KE; Jones SM; Burns RH; Huang CT
J Pharm Sci; 1990 May; 79(5):384-8. PubMed ID: 2161922
[TBL] [Abstract][Full Text] [Related]
19. [Inhibitory effect of N-alpha-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (MK-0521) on angiotensin converting enzyme in vitro].
Ino Y; Oda M; Sato T; Iwaki M
Nihon Yakurigaku Zasshi; 1989 Apr; 93(4):219-24. PubMed ID: 2545578
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
Rodrigues MS; Schaffel R; Assreuy J
Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
